Felicity Grzemski

Jun 7, 2023 | clinicalleader.com | Kerry Leyden |Judson Chase |Felicity Grzemski

ISR Reports has been filling the need for higher-quality market research in the pharmaceutical industry for over 15 years. Utilizing a rigorous primary research methodology, ISR offers off-the-shelf reports, as well as unparalleled custom research services. Their website also hosts several free resources covering topics such as CDMO and CRO selection, clinical development, drug manufacturing, eClinical technology, decentralized trials, the cell and gene market, and more. Visit ISR's homepage here.

May 9, 2023 | clinicalleader.com | Felicity Grzemski

By Felicity Grzemski, PhD, DABT Drug development is a pricy, intricate, and regulated process that must always be treated with care and attention to detail. The disconnect between preclinical research and clinical development, where the translation has a success rate of less than 10%, is just one potential problem with early drug development.

May 9, 2023 | cellandgene.com | Felicity Grzemski

By Felicity Grzemski, PhD, DABT Drug development is a pricy, intricate, and regulated process that must always be treated with care and attention to detail. The disconnect between preclinical research and clinical development, where the translation has a success rate of less than 10%, is just one potential problem with early drug development.